BlackRock Global Funds - European Equity Income Fund D2 USD HedgedRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -1.4 | 23.1 | 2.8 | 10.9 | 9.1 | |
+/-Cat | - | - | - | - | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Other Equity | ||||||
Category Benchmark: - |
Key Stats | ||
NAV 21/11/2024 | USD 18.79 | |
Day Change | 0.43% | |
Morningstar Category™ | Other Equity | |
ISIN | LU1185942585 | |
Fund Size (Mil) 31/10/2024 | EUR 1461.32 | |
Share Class Size (Mil) 21/11/2024 | USD 6.80 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 30/01/2024 | 1.07% |
Investment Objective: BlackRock Global Funds - European Equity Income Fund D2 USD Hedged |
The Fund seeks an above average income from its equity investments without sacrificing long term capital growth. The Fund invests at least 70% of its total assets in equity securities of companies domiciled in, or exercising the predominant part of their economic activity in, Europe. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Andreas Zoellinger 03/12/2010 | ||
Brian Hall 01/03/2021 | ||
Inception Date 25/02/2015 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for BlackRock Global Funds - European Equity Income Fund D2 USD Hedged | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 4.27 |
Enel SpA | Utilities | 4.05 |
Compagnie de Saint-Gobain SA | Industrials | 3.24 |
AstraZeneca PLC | Healthcare | 3.21 |
UniCredit SpA | Financial Services | 3.18 |
Increase Decrease New since last portfolio | ||
BlackRock Global Funds - European Equity Income Fund D2 USD Hedged |